Literature DB >> 8220884

Estimation of partial agonist affinity by interaction with a full agonist: a direct operational model-fitting approach.

P Leff1, I G Dougall, D Harper.   

Abstract

1. The operational model of agonism (Black & Leff, 1983) has been extended to describe the interaction between a partial agonist and a full agonist at the same receptor. The derived equation explicitly describes the interaction and allows the affinity (and efficacy) of the partial agonist to be estimated by direct fitting of raw experimental agonist concentration-effect (E/[A]) curve data. 2. The model was used to analyse experimental E/[A] curve data generated for the interaction between pilocarpine (partial agonist) and carbachol (full agonist) at the M3-muscarinic receptor mediating contraction of the guinea-pig isolated trachea. Pilocarpine affinity estimates obtained by operational model-fitting were compared with those obtained by use of the null method (Stephenson, 1956). These analyses demonstrated that the two methods gave comparable results (mean pKB estimates were 5.79 and 5.86 for the operational model and null method respectively). 3. When multiple concentrations of partial agonist are used, simultaneous operational model-fitting of all the E/[A] curve data allows the competitive nature of the interaction to be studied. 4. We conclude that operational model-fitting is a valid and analytically simple alternative to the conventional null method of analysing full/partial agonist interactions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8220884      PMCID: PMC2176040          DOI: 10.1111/j.1476-5381.1993.tb13799.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  7 in total

1.  A modification of receptor theory.

Authors:  R P STEPHENSON
Journal:  Br J Pharmacol Chemother       Date:  1956-12

2.  On the statistics of drug-receptor constants for partial agonists.

Authors:  M Marano; A J Kaumann
Journal:  J Pharmacol Exp Ther       Date:  1976-09       Impact factor: 4.030

3.  Estimation of agonist affinity and efficacy by direct, operational model-fitting.

Authors:  P Leff; D J Prentice; H Giles; G R Martin; J Wood
Journal:  J Pharmacol Methods       Date:  1990-05

4.  Operational models of pharmacological agonism.

Authors:  J W Black; P Leff
Journal:  Proc R Soc Lond B Biol Sci       Date:  1983-12-22

5.  On equilibrium dissociation constants for complexes of drug-receptor subtypes. Selective and non-selective interactions of partial agonists with two plausible beta-adrenoceptor subtypes mediating positive chronotropic effects of (-)-isoprenaline in kitten atria.

Authors:  A J Kaumann; M Marano
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-02       Impact factor: 3.000

6.  The affinity and efficacy of onium salts on the frog rectus abdominis.

Authors:  R B Barlow; N C Scott; R P Stephenson
Journal:  Br J Pharmacol Chemother       Date:  1967-09

7.  An operational model of pharmacological agonism: the effect of E/[A] curve shape on agonist dissociation constant estimation.

Authors:  J W Black; P Leff; N P Shankley; J Wood
Journal:  Br J Pharmacol       Date:  1985-02       Impact factor: 8.739

  7 in total
  9 in total

1.  Pharmacological analysis of cannabinoid receptor activity in the rat vas deferens.

Authors:  A Christopoulos; P Coles; L Lay; M J Lew; J A Angus
Journal:  Br J Pharmacol       Date:  2001-03       Impact factor: 8.739

2.  Analysis of the action of idazoxan calls into question the reliability of the rat isolated small mesenteric artery assay as a predictor for alpha 1-adrenoceptor-mediated pressor activity.

Authors:  P H Van der Graaf; N P Shankley; J W Black
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996 Aug-Sep       Impact factor: 3.000

3.  Allosteric modulation of the M₃ muscarinic receptor by amiodarone and N-ethylamiodarone: application of the four-ligand allosteric two-state model.

Authors:  Edward Stahl; Gwendolynne Elmslie; John Ellis
Journal:  Mol Pharmacol       Date:  2011-05-20       Impact factor: 4.436

4.  Development of operational models of receptor activation including constitutive receptor activity and their use to determine the efficacy of the chemokine CCL17 at the CC chemokine receptor CCR4.

Authors:  R J Slack; D A Hall
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739

5.  A novel mechanism of G protein-coupled receptor functional selectivity. Muscarinic partial agonist McN-A-343 as a bitopic orthosteric/allosteric ligand.

Authors:  Celine Valant; Karen J Gregory; Nathan E Hall; Peter J Scammells; Michael J Lew; Patrick M Sexton; Arthur Christopoulos
Journal:  J Biol Chem       Date:  2008-08-22       Impact factor: 5.157

6.  Methodical Challenges and a Possible Resolution in the Assessment of Receptor Reserve for Adenosine, an Agonist with Short Half-Life.

Authors:  Judit Zsuga; Tamas Erdei; Katalin Szabó; Nora Lampe; Csaba Papp; Akos Pinter; Andras Jozsef Szentmiklosi; Bela Juhasz; Zoltán Szilvássy; Rudolf Gesztelyi
Journal:  Molecules       Date:  2017-05-19       Impact factor: 4.411

7.  Applications and limitations of fitting of the operational model to determine relative efficacies of agonists.

Authors:  Jan Jakubík; Alena Randáková; Vladimír Rudajev; Pavel Zimčík; Esam E El-Fakahany; Vladimír Doležal
Journal:  Sci Rep       Date:  2019-03-15       Impact factor: 4.379

8.  Detection of the secondary, low-affinity β1 -adrenoceptor site in living cells using the fluorescent CGP 12177 derivative BODIPY-TMR-CGP.

Authors:  K Gherbi; S J Briddon; S J Hill
Journal:  Br J Pharmacol       Date:  2014-12       Impact factor: 8.739

9.  The operational model of allosteric modulation of pharmacological agonism.

Authors:  Jan Jakubík; Alena Randáková; Nikolai Chetverikov; Esam E El-Fakahany; Vladimír Doležal
Journal:  Sci Rep       Date:  2020-09-02       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.